×
For best experience we recommend to activate Javascript in your browser.
Recombinant CALCA, CALCB (Galcanezumab Biosimilar) antibody
This anti-CALCA, CALCB (Galcanezumab Biosimilar) antibody is a Human Monoclonal antibody detecting CALCA, CALCB (Galcanezumab Biosimilar) in FACS and in vivo. Suitable for Human.
Catalog No. ABIN7795165
$237.02
$278.85
save $41.83 (-15 %)
Plus shipping costs $50.00
Delivery in 21 to 26 Business Days
Quick Overview for Recombinant CALCA, CALCB (Galcanezumab Biosimilar) antibody (ABIN7795165)
Target
CALCA, CALCB (Galcanezumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for CALCA, CALCB (Galcanezumab Biosimilar) antibodies
Human
Clonality
All clonalities for CALCA, CALCB (Galcanezumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for CALCA, CALCB (Galcanezumab Biosimilar) antibodies
This CALCA, CALCB (Galcanezumab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), In vivo Studies (in vivo)
Grade
Research Grade
Product Details anti-CALCA, CALCB (Galcanezumab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Galcanezumab Biosimilar, CALCA/CGRP1/CALCB/CGRP2 Monoclonal Antibody
Characteristics
The anti-human CALCA/CGRP1/CALCB/CGRP2 monoclonal antibody galcanezumab biosimilar was produced in mammalian cells.
Purification
Protein A or G affinity column
Purity
>95 % by reducing SDS-PAGE
Endotoxin Level
< 1 EU per 1 mg of the protein by the LAL method
Isotype
IgG4, kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
> 3 mg/mL
Storage
4 °C,-20 °C
Storage Comment
Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
Target Details for CALCA, CALCB (Galcanezumab Biosimilar)
(hide)
Target
CALCA, CALCB (Galcanezumab Biosimilar)
Alternative Name
Galcanezumab Biosimilar
Target Type
Biosimilar
Recently viewed
(hide)
Chat with us , powered by LiveChat